Terms: = Kidney tumors AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Prognosis
24 results:
1. VDRA downregulate β-catenin/Smad3 and DNA damage and repair associated with improved prognosis in ccRCC patients.
Wang P; Nie J; Li J; Ye C; Chen J; Zhang Z; Li B
Int J Biol Macromol; 2024 Apr; 263(Pt 2):130405. PubMed ID: 38403213
[TBL] [Abstract] [Full Text] [Related]
2. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
3. Mature B-cell lymphoma with acute myelitis as the first presentation: a case report and literature review.
Fan Y; Zeng GH; Xiao W; Yu JM; Zhang XD
BMC Neurol; 2023 Mar; 23(1):111. PubMed ID: 36932413
[TBL] [Abstract] [Full Text] [Related]
4. Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer.
Lopez de Rodas M; Nagineni V; Ravi A; Datar IJ; Mino-Kenudson M; Corredor G; Barrera C; Behlman L; Rimm DL; Herbst RS; Madabhushi A; Riess JW; Velcheti V; Hellmann MD; Gainor J; Schalper KA
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35649657
[TBL] [Abstract] [Full Text] [Related]
5. cd20
Wu Z; Zhou J; Xiao Y; Ming J; Zhou J; Dong F; Zhou X; Xu Z; Zhao X; Lei P; Huang T
Front Immunol; 2022; 13():865596. PubMed ID: 35634306
[TBL] [Abstract] [Full Text] [Related]
6. Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.
Terry S; Dalban C; Rioux-Leclercq N; Adam J; Meylan M; Buart S; Bougoüin A; Lespagnol A; Dugay F; Moreno IC; Lacroix G; Lorens JB; Gausdal G; Fridman WH; Mami-Chouaib F; Chaput N; Beuselinck B; Chabaud S; Barros-Monteiro J; Vano Y; Escudier B; Sautès-Fridman C; Albiges L; Chouaib S
Clin Cancer Res; 2021 Dec; 27(24):6749-6760. PubMed ID: 34407968
[TBL] [Abstract] [Full Text] [Related]
7. Nuclear and stromal expression of Manic fringe in renal cell carcinoma.
Cheng WK; Kaur G; Sjöberg E; Frödin M; Egevad L; Harmenberg U; Li JL; Oon CE
Exp Mol Pathol; 2021 Oct; 122():104667. PubMed ID: 34371013
[TBL] [Abstract] [Full Text] [Related]
8. Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma.
Armstrong AJ; Nixon AB; Carmack A; Yang Q; Eisen T; Stadler WM; Jones RJ; Garcia JA; Vaishampayan UN; Picus J; Hawkins RE; Hainsworth JD; Kollmannsberger CK; Logan TF; Puzanov I; Pickering LM; Ryan CW; Protheroe A; George DJ; Halabi S
Clin Cancer Res; 2021 Jun; 27(12):3317-3328. PubMed ID: 33593885
[TBL] [Abstract] [Full Text] [Related]
9. Omics-wide quantitative B-cell infiltration analyses identify GPR18 for human cancer prognosis with superiority over cd20.
Liu Y; Wang L; Lo KW; Lui VWY
Commun Biol; 2020 May; 3(1):234. PubMed ID: 32398659
[TBL] [Abstract] [Full Text] [Related]
10. A minority-group of renal cell cancer patients with high infiltration of cd20+B-cells is associated with poor prognosis.
Sjöberg E; Frödin M; Lövrot J; Mezheyeuski A; Johansson M; Harmenberg U; Egevad L; Sandström P; Östman A
Br J Cancer; 2018 Oct; 119(7):840-846. PubMed ID: 30293996
[TBL] [Abstract] [Full Text] [Related]
11. [Clinicopathologic features of primary mucosal CD30-positive T-cell lymphoproliferative disorders in head and neck region].
Liu F; Li M; Zhang LY; Guo L; Hu WW; Rao HL
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):412-416. PubMed ID: 29886583
[No Abstract] [Full Text] [Related]
12. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
[TBL] [Abstract] [Full Text] [Related]
13. Expression of HMGB1/RAGE protein in renal carcinoma and its clinical significance.
Qie GQ; Wang CT; Chu YF; Wang R
Int J Clin Exp Pathol; 2015; 8(6):6262-8. PubMed ID: 26261503
[TBL] [Abstract] [Full Text] [Related]
14. [Critical care of Onco-hematology patients: new therapeutic targets, new complications and new admission policies].
Lengline E; Darmon M; Azoulay E; Le Gall JR
Bull Acad Natl Med; 2015; 199(2-3):293-312. PubMed ID: 27476311
[TBL] [Abstract] [Full Text] [Related]
15. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
[TBL] [Abstract] [Full Text] [Related]
16. Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma.
Xue YJ; Xiao RH; Long DZ; Zou XF; Wang XN; Zhang GX; Yuan YH; Wu GQ; Yang J; Wu YT; Xu H; Liu FL; Liu M
J Transl Med; 2012 Sep; 10():200. PubMed ID: 23006512
[TBL] [Abstract] [Full Text] [Related]
17. Renal sinus pseudolymphoma in a patient with multiple carcinomas: a case report and a brief review of the literature.
Ambrosio MR; Rocca BJ; Onorati M; Bellan C; Barbanti G; del Vecchio MT; Tripodi S
Histol Histopathol; 2012 Oct; 27(10):1327-32. PubMed ID: 22936451
[TBL] [Abstract] [Full Text] [Related]
18. [Three cases of primary renal lymphoma].
Fang FS; Zhu HL; Song ZG; Lu XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1107-11. PubMed ID: 17956701
[TBL] [Abstract] [Full Text] [Related]
19. [Epithelioid angiomyolipoma of kidney: clinicopathologic study of two cases and review of literature].
Meng YH; Pei F; Lu P; Yu JY; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):19-23. PubMed ID: 17374233
[TBL] [Abstract] [Full Text] [Related]
20. Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients.
Ikuerowo SO; Kuczyk MA; Mengel M; van der Heyde E; Shittu OB; Vaske B; Jonas U; Machtens S; Serth J
Int J Cancer; 2006 Aug; 119(4):867-74. PubMed ID: 16557593
[TBL] [Abstract] [Full Text] [Related]
[Next]
